AbbVie
ABBV
#32
Rank
$294.65 B
Marketcap
$166.41
Share price
1.06%
Change (1 day)
4.27%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Operating Margin for AbbVie (ABBV)

Operating Margin as of April 2024 (TTM): 18.65%

According to AbbVie's latest financial reports and stock price the company's current Operating Margin is 18.65%. At the end of 2022 the company had an Operating Margin of 23.21%.

Operating Margin history for AbbVie from 2011 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202223.21%0.44%
202123.11%211.56%
20207.42%-70.71%
201925.33%59.63%
201815.87%-42.06%
201727.39%-10.95%
201630.75%5.79%
201529.07%144.93%
201411.87%-58.17%
201328.38%-8.9%
201231.15%48.11%
201121.03%-31.99%
201030.92%-26.13%
200941.86%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
34.61% 85.58%๐Ÿ‡บ๐Ÿ‡ธ USA
24.66% 32.23%๐Ÿ‡บ๐Ÿ‡ธ USA
34.59% 85.47%๐Ÿ‡บ๐Ÿ‡ธ USA
31.30% 67.83%๐Ÿ‡บ๐Ÿ‡ธ USA
26.84% 43.91%๐Ÿ‡บ๐Ÿ‡ธ USA
19.24% 3.16%๐Ÿ‡บ๐Ÿ‡ธ USA
5.63%-69.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
22.54% 20.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
14.36%-23.00%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.